View More Recent Stories

Jan 23, 2025 04:48AM Increasing unusual put option volume: TAL XP CHD MLCO EXC PCG GH RGTI WMB ICE TEM IYR
Jan 21, 2025 01:00PM Raymond James Reiterates Outperform Rating on Guardant Health (GH)
Jan 21, 2025 01:00PM Raymond James Reiterates Outperform Rating on Guardant Health (GH)
Jan 21, 2025 11:50AM TD Cowen Reiterates Buy Rating on Guardant Health (GH)
Jan 21, 2025 11:28AM Guardant Health (GH) PT Raised to $55 at BTIG
Jan 21, 2025 11:07AM Canaccord Genuity Reiterates Buy Rating on Guardant Health (GH)
Jan 16, 2025 08:10AM Guardant Health (GH) and ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
Jan 10, 2025 09:18AM Guardant Health (GH) named top pick at UBS
Jan 7, 2025 11:58AM Jefferies Reiterates Buy Rating on Guardant Health (GH)
Jan 3, 2025 07:46AM Piper Sandler Reiterates Overweight Rating on Guardant Health (GH) After a 'Positive' Survey
Dec 18, 2024 08:06AM Guardant Health (GH) Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Nov 7, 2024 05:56AM Guardant Health (GH) PT Raised to $60 at Leerink Partners
Nov 6, 2024 04:41PM Guardant Health (GH) Tops Q3 EPS by 29c ; Offers Guidance
Oct 24, 2024 05:06PM Guardant Health (GH) Appoints Roberto A. Mignone to its Board
Sep 16, 2024 07:18AM Guardant Health (GH) Weakness Said to be Tied to Data From Exact Sciences (EXAS)
Aug 26, 2024 11:50AM Midday movers: PDD Holdings, NVIDIA fall; Xpeng gains
Aug 26, 2024 08:38AM Guardant Health (GH) enters Open Market Sale Agreement with Jefferies
Aug 8, 2024 09:29AM Guardant Health (GH) PT Raised to $42 at TD Cowen
Aug 8, 2024 06:47AM Guardant Health (GH) PT Raised to $40 at Jefferies
Aug 7, 2024 04:46PM Guardant Health (GH) Tops Q2 EPS by 26c ; Offers Guidance
Aug 1, 2024 08:33AM Guardant Health's (GH) FDA-approved Shield Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
Jul 29, 2024 03:44PM Guardant Health (GH) PT Raised to $50 at BTIG, 'one of our top two picks in 2024'
Jul 29, 2024 07:44AM Exact Sciences (EXAS) Slips 5% After Rival Colorectal Cancer Test Approved by FDA
Jul 29, 2024 07:34AM Guardant Health's (GH) Shield Blood Test Approved by FDA as Primary Screening Option, Clearing Path for Medicare Reimbursement
Jul 23, 2024 08:17AM Guardant Health (GH) Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360 Test
Jul 18, 2024 05:01PM Guardant Health (GH) Appoints Manuel Hidalgo Medina to its Board
View More Recent Stories